Clinical Trial Update: A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features

View source ↗

Summary

This clinical trial update describes a real-world study of Deucravacitinib for moderate-to-severe plaque psoriasis with eczematous features. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Plaque Psoriasis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Xi Tan | Conditions: Psoriasis, Eczema | Status: ENROLLING_BY_INVITATION